Sarah Cannon Research Institute
at HealthONE
Sarah Cannon Research Institute at HealthONE in Denver, Colorado is
determined to make a difference in our patients’ lives. As a member of Sarah
Cannon Research Institute (SCRI), we are a part of a network that has
conducted community-based clinical trials for more than 20 years and has
administered more than 170 first-in-man clinical trials to date.
Sarah Cannon Research Institute at HealthONE
Services and Resources
Sarah Cannon Research Institute at HealthONE is part of Sarah
Cannon, the global cancer enterprise of HealthONE’s parent
company, Hospital Corporation of America (HCA). Together,
Sarah Cannon and HealthONE offer integrated cancer services
to communities across the greater Denver area, which can be
accessed at the HealthONE family of hospitals. Through our
partnership, we pair cutting-edge research with world-class
cancer services that span the entire cancer care journey from
diagnosis through survivorship.
• Extensive clinical trials menu
Program Growth
SCRI’s drug development unit has conducted more than 170
first-in-man clinical trials and experienced an annual average
growth rate of 15-20 percent in patient enrollment.
We are committed to our partners’ goals, and we tailor our
teams and processes to meet them. Senior-level management
and clinical staff stay involved throughout our working
relationship, ensuring strong science and consistent quality
every step of the way. We serve as collaborators and research
consultants, and we strive to provide informed scientific
insights that contribute to success, discovery, and
faster answers.
•
•
•
•
Expansive clinic with patient lounge area
Private treatment room
On-site pharmacy for patient convenience
Wireless Internet and televisions with wireless headphones
SCRI’s Drug Development Program offers
sponsors consistent performance and research
excellence through:
•
•
•
•
Strict adherence to eligibility criteria
A dedicated pharmacokinetic team
Rapid accrual
Interactive scientific collaboration
Locations providing
you state-of-theart care.
Learn more at:
sarahcannon.com/
locations
Nashville
Est. 1998
sarahcannonresearch.com/denver
Sarasota
Est. 2009
Oklahoma City
Est. 2009
London
Est. 2010
Denver
Est. 2014
Sarah Cannon Research Institute at HealthONE
We have a fully-staffed nursing and clinical research team, including principal
investigators, clinic and research nurses, clinical trial managers, data
coordinators, regulatory affairs specialists, pharmacy technicians, and day
and evening pharmacokinetic technicians.
Gerald S. Falchook MD, MS
Director, Drug Development Program at SCRI at HealthONE
Gerald Falchook, MD, MS, is the Director of Drug Development
at Sarah Cannon Research Institute at HealthONE. Dr. Falchook
completed his oncology training at MD Anderson Cancer Center,
where he also served as a faculty member for six years,
developing investigator-initiated clinical trials, as well as
collaborating with pharma/biotech industry partners to
bring promising new drugs to cancer patients.
Dr. Falchook has been the principal investigator or coinvestigator of more than 160 clinical studies, including the
first-in-human studies and regimens that have received FDA
approval. His research has been published extensively, with
more than 90 publications in peer-reviewed journals, as
well as more than 150 abstracts at national and
international conferences.
Accompanying Staff
Lindsay Bramwell RN, ACNS-BC
Dave Oeser, PharmD
Advanced Practice Nurse, Research Nurse
Director of Pharmacy
Sue Carlson MLT ASCP
Lisa R. Salzman
Laboratory
Registrar
Brian W. Herrick
Pete Schlickman, PharmD
Clinical Trial Specialist
Pharmacist
Krista Hodges RN, OCN
Jason Sortor, MLS (ASCP)
Treatment Nurse
Laboratory
Yesenia Mastasche
Lenora Zancanella, MT (ASCP)
Laboratory
Laboratory Director
above:
SCRI at HealthONE Facility
Kelly Mozzetta
Operations Manager
Above all else, we are committed to the improvement of
patient outcomes and advancement of medical science
through innovation and quality execution of cancer research.
sarahcannonresearch.com/denver
If you are interested in finding out
more information related to our clinical
trials, please contact:
Sarah Cannon Research Institute
at HealthONE
1800 Williams Street, Suite 300
Denver, CO 80218
720.754.2610